Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.

Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.
复制标题

DOI:
10.1093/jnci/djp078
复制
发表时间:
2009-05
期刊:
Journal of the National Cancer Institute
影响因子:
--
通讯作者:
Xiangsheng Zuo;Zhanglong Peng;M. Moussalli;Jeffrey S. Morris;R. Broaddus;S. Fischer;I. Shureiqi
Xiangsheng Zuo;Zhanglong Peng;M. Moussalli;Jeffrey S. Morris;R. Broaddus;S. Fischer;I. Shureiqi
中科院分区:
其他
文献类型:
--
作者:
Xiangsheng Zuo;Zhanglong Peng;M. Moussalli;Jeffrey S. Morris;R. Broaddus;S. Fischer;I. Shureiqi

文献摘要

被引文献

相似文献

过氧化物酶体增殖物激活受体-δ(PPAR-delta)在人类结肠癌中过表达,但其对结肠肿瘤发生的作用存在争议。我们建立了一种小鼠模型,其中通过外显子4的靶向缺失,在结肠上皮细胞中对PPAR-delta进行遗传破坏。通过实时逆转录-聚合酶链反应(实时RT-PCR)、免疫印迹和活性测定证实了结肠特异性PPAR-delta表达的消除。测试具有和不具有靶向PPAR-delta遗传破坏的小鼠(每组10-11只小鼠)的氧化偶氮甲烷诱导的结肠肿瘤的发生率。通过实时定量RT-PCR测定靶向PPAR-delta缺失对血管内皮生长因子表达的影响。靶向PPAR-delta基因破坏抑制结肠癌发生:具有PPAR-delta(-/-)结肠的小鼠比野生型小鼠少98.5%的肿瘤(PPAR-delta((-/-))vs野生型,平均值= 0.1个肿瘤/小鼠vs 6.6个肿瘤/小鼠,差异= 6.5个肿瘤/小鼠,95%置信区间= 4.9至8.0个肿瘤/小鼠,P <0.001,双侧检验)。与正常结肠相比,结肠肿瘤中血管内皮生长因子表达的增加被PPAR-delta表达的丧失抑制。这些发现表明PPAR-delta在促进结肠肿瘤发生中具有关键作用。
Peroxisome proliferator-activated receptor-delta (PPAR-delta) is overexpressed in human colon cancer, but its contribution to colonic tumorigenesis is controversial. We generated a mouse model in which PPAR-delta was genetically disrupted in colonic epithelial cells by targeted deletion of exon 4. Elimination of colon-specific PPAR-delta expression was confirmed by real-time reverse transcription-polymerase chain reaction (real-time RT-PCR), immunoblotting, and activity assays. Mice with and without targeted PPAR-delta genetic disruption (10-11 mice per group) were tested for incidence of azoxymethane-induced colon tumors. The effects of targeted PPAR-delta deletion on vascular endothelial growth factor expression were determined by real-time RT-PCR. Targeted PPAR-delta genetic disruption inhibited colonic carcinogenesis: Mice with PPAR-delta((-/-)) colons developed 98.5% fewer tumors than wild-type mice (PPAR-delta((-/-)) vs wild-type, mean = 0.1 tumors per mouse vs 6.6 tumors per mouse, difference = 6.5 tumors per mouse, 95% confidence interval = 4.9 to 8.0 tumors per mouse, P < .001, two-sided test). Increased expression of vascular endothelial growth factor in colon tumors vs normal colon was suppressed by loss of PPAR-delta expression. These findings indicate that PPAR-delta has a crucial role in promoting colonic tumorigenesis.